Skip to main content

LENSAR, Inc. (LNSR) Stock Forecast 2025 - AI Price Prediction & Analysis


LENSAR, Inc. (LNSR) AI Stock Price Forecast & Investment Analysis

LENSAR, Inc. Stock Price Chart and Technical Analysis

Loading LENSAR, Inc. interactive price chart and technical analysis...

LENSAR, Inc. (LNSR) - Comprehensive Stock Analysis & Investment Research

Deep dive into LENSAR, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about LENSAR, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For LENSAR, Inc.: LENSAR, Inc. operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

LENSAR, Inc. (Stock Symbol: LNSR) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry.

The organization employs approximately 138 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing LENSAR, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For LENSAR, Inc.: With $58M in annual revenue and -34.0% net margin, the company demonstrates developing profitability.

Annual Revenue: $58 million generating a -34.0% net profit margin .

Market Capitalization: $141 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -37.0% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for LENSAR, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For LENSAR, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for LENSAR, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: LENSAR, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For LENSAR, Inc.: Market positioning analysis based on available financial and operational metrics.

LENSAR, Inc. strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 49.9% gross margin, indicating strong pricing power and operational efficiency.

LENSAR, Inc. (LNSR) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for LENSAR, Inc. stock analysis.

Loading LENSAR, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into LENSAR, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if LENSAR, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For LENSAR, Inc.: With a P/E ratio of -6.68, the market sees the stock as potentially undervalued.

P/E Ratio -6.68x
P/B Ratio -6.98x
Market Cap $141M
EPS $-4.21
Book Value/Share $-1.88
Revenue/Share $4.89
FCF/Share $-1.78
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently LENSAR, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For LENSAR, Inc.: An ROE of -37.0% indicates room for improvement in shareholder value creation.

ROE -37.0%
ROA -31.5%
ROIC -34.9%
Gross Margin 49.9%
Operating Margin -25.2%
Net Margin -34.0%
EBT Margin -57.4%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess LENSAR, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For LENSAR, Inc.: A current ratio of 4.97 indicates strong liquidity.

Current Ratio 4.97x
Quick Ratio 4.22x
D/E Ratio 0.05x
Financial Leverage 1.21x
Interest Coverage -324.2x
Working Capital $50M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal LENSAR, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For LENSAR, Inc.: Free cash flow of $-7M indicates cash challenges that need attention.

Operating Cash Flow $-7M
Free Cash Flow $-7M
FCF/Sales -19.7%
CapEx/Sales 0.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively LENSAR, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For LENSAR, Inc.: An asset turnover of 0.55x suggests room for improvement in asset utilization.

Asset Turnover 0.55x
Receivables Turnover 12.9x
Inventory Turnover 2.1x
Fixed Assets Turnover 5.9x
Days Sales Outstanding 28 days
Days Inventory 174 days
Payables Period 46 days
Cash Conversion Cycle 157 days
Understanding Financial Statement Data

What these metrics mean: Key figures from LENSAR, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For LENSAR, Inc.: With annual revenue of $58M, LENSAR, Inc. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $58M
R&D Expense $5M
SG&A Expense $66M
Cost of Goods Sold $16M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 64%
Cash & Short-term Investments 48%
Total Liabilities 17%
Accounts Receivable 6%
Inventory 7%
Dividend & Shareholder Information
Shares Outstanding 12M
Growth Metrics (YoY)
EPS Growth -9.3%

Latest LENSAR, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting LENSAR, Inc. (LNSR) stock price and investment outlook.

📰 We are currently updating our news feed for LENSAR, Inc.. Check back soon for the latest market analysis and company updates.

LENSAR, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of LENSAR, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADGM Unlock Forecast - 30 Days FREE Trial $21M x 2.4x
ALUR Unlock Forecast - 30 Days FREE Trial $15M -0.4x -0.3x
ANGO Unlock Forecast - 30 Days FREE Trial $478M -1.4x 2.7x
ANIK Unlock Forecast - 30 Days FREE Trial $132M -4.3x 0.9x
AORT Unlock Forecast - 30 Days FREE Trial $1873M -198.2x 4.5x
APYX Unlock Forecast - 30 Days FREE Trial $110M -3.5x 15.2x
ATEC Unlock Forecast - 30 Days FREE Trial $2152M -7.4x 90.5x
ATRC Unlock Forecast - 30 Days FREE Trial $1857M -39.6x 4.0x
AVHHL Unlock Forecast - 30 Days FREE Trial $30M x x
BAX Unlock Forecast - 30 Days FREE Trial $11807M -94.9x 1.6x
BBNX Unlock Forecast - 30 Days FREE Trial $870M x 2.9x
BDX Unlock Forecast - 30 Days FREE Trial $53486M 33.7x 2.1x
BEAT Unlock Forecast - 30 Days FREE Trial $58M -5.7x 13.9x
BJDX Unlock Forecast - 30 Days FREE Trial $4M -0.5x 0.7x
BSX Unlock Forecast - 30 Days FREE Trial $146015M 58.3x 6.5x
BVS Unlock Forecast - 30 Days FREE Trial $458M -18.3x 2.8x
CARL Unlock Forecast - 30 Days FREE Trial $62M x x
CLPT Unlock Forecast - 30 Days FREE Trial $721M -23.5x 36.5x
CODX Unlock Forecast - 30 Days FREE Trial $12M -0.7x 0.3x
CVRX Unlock Forecast - 30 Days FREE Trial $260M -5.5x 4.5x
DCTH Unlock Forecast - 30 Days FREE Trial $418M 187.5x 4.0x
DRTS Unlock Forecast - 30 Days FREE Trial $319M x 3.7x
DXCM Unlock Forecast - 30 Days FREE Trial $26015M 45.5x 10.1x
EBRCZ Unlock Forecast - 30 Days FREE Trial $427M x 8.6x
FEMY Unlock Forecast - 30 Days FREE Trial $23M -1.4x 15.2x
FOFA Unlock Forecast - 30 Days FREE Trial $7M x 12.7x
GIPL Unlock Forecast - 30 Days FREE Trial $7M x 36.1x
GKOS Unlock Forecast - 30 Days FREE Trial $4885M -46.3x 6.4x
GMED Unlock Forecast - 30 Days FREE Trial $8091M 22.7x 1.9x
HRGN Unlock Forecast - 30 Days FREE Trial $29M x 38.2x
IART Unlock Forecast - 30 Days FREE Trial $1128M 200.2x 1.1x
ICCM Unlock Forecast - 30 Days FREE Trial $48M x 16.6x
ICUI Unlock Forecast - 30 Days FREE Trial $2926M -49.8x 1.4x
IDXG Unlock Forecast - 30 Days FREE Trial $4M 0.8x -0.9x
IINN Unlock Forecast - 30 Days FREE Trial $27M x 6.2x
IINNW Unlock Forecast - 30 Days FREE Trial $10M x 2.4x
INBS Unlock Forecast - 30 Days FREE Trial $8M -0.3x 2.5x
INFU Unlock Forecast - 30 Days FREE Trial $184M 36.2x 3.4x
INSP Unlock Forecast - 30 Days FREE Trial $2310M 43.5x 3.4x
IRMD Unlock Forecast - 30 Days FREE Trial $929M 45.0x 9.9x
IRTC Unlock Forecast - 30 Days FREE Trial $5812M -20.2x 56.1x
KIDS Unlock Forecast - 30 Days FREE Trial $402M -20.7x 1.1x
KMTS Unlock Forecast - 30 Days FREE Trial $1196M x x
KRMD Unlock Forecast - 30 Days FREE Trial $187M -19.8x 11.3x
LNSR Unlock Forecast - 30 Days FREE Trial $141M -6.7x -7.0x
LUCD Unlock Forecast - 30 Days FREE Trial $120M -0.6x 15.3x
LUNG Unlock Forecast - 30 Days FREE Trial $62M -4.3x 0.9x
MCAG Unlock Forecast - 30 Days FREE Trial $33M x -9.6x
MCAGU Unlock Forecast - 30 Days FREE Trial $31M x -9.9x
MDNC Unlock Forecast - 30 Days FREE Trial $59M 26.2x 12.2x
MDXG Unlock Forecast - 30 Days FREE Trial $970M 30.2x 4.5x
MGRM Unlock Forecast - 30 Days FREE Trial $217M -10.7x 25.1x
MHUA Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
MMM Unlock Forecast - 30 Days FREE Trial $80645M 20.5x 18.8x
MMSI Unlock Forecast - 30 Days FREE Trial $4848M 40.7x 3.3x
NEPH Unlock Forecast - 30 Days FREE Trial $52M 39.1x 6.2x
NMTC Unlock Forecast - 30 Days FREE Trial $41M -1.7x 5.0x
NPCE Unlock Forecast - 30 Days FREE Trial $344M -10.4x 17.7x
NSPR Unlock Forecast - 30 Days FREE Trial $76M -4.3x 3.7x
NVCR Unlock Forecast - 30 Days FREE Trial $1531M -20.8x 4.4x
NXGL Unlock Forecast - 30 Days FREE Trial $20M -6.8x 4.3x
OBIO Unlock Forecast - 30 Days FREE Trial $128M -3.4x 1.3x
OFIX Unlock Forecast - 30 Days FREE Trial $595M -5.8x 1.3x
OSRH Unlock Forecast - 30 Days FREE Trial $11M x 0.1x
OSUR Unlock Forecast - 30 Days FREE Trial $223M 17.1x 0.6x
PAVM Unlock Forecast - 30 Days FREE Trial $10M 0.1x 0.3x
PDEX Unlock Forecast - 30 Days FREE Trial $86M 9.5x 2.3x
PEN Unlock Forecast - 30 Days FREE Trial $9954M 67.4x 7.7x
PLRZ Unlock Forecast - 30 Days FREE Trial $6M x 0.3x
PMI Unlock Forecast - 30 Days FREE Trial $90M x x
PODD Unlock Forecast - 30 Days FREE Trial $22506M 95.3x 15.4x
PRCT Unlock Forecast - 30 Days FREE Trial $1877M -45.4x 4.9x
PROF Unlock Forecast - 30 Days FREE Trial $166M x 4.2x
PYPD Unlock Forecast - 30 Days FREE Trial $51M x 2.5x
RCEL Unlock Forecast - 30 Days FREE Trial $106M -5.0x -29.9x
RDGL Unlock Forecast - 30 Days FREE Trial $35M x 13.0x
RMD Unlock Forecast - 30 Days FREE Trial $39524M 28.2x 6.6x
RSMDF Unlock Forecast - 30 Days FREE Trial $3625M 2.6x 0.6x
RTGN Unlock Forecast - 30 Days FREE Trial $66M x x
RVP Unlock Forecast - 30 Days FREE Trial $27M -0.9x 0.4x
SGHT Unlock Forecast - 30 Days FREE Trial $244M -3.7x 3.5x
SIBN Unlock Forecast - 30 Days FREE Trial $634M -14.3x 3.7x
SKIN Unlock Forecast - 30 Days FREE Trial $181M -1.8x 2.5x
SNOA Unlock Forecast - 30 Days FREE Trial $6M -5.6x 1.6x
SNWV Unlock Forecast - 30 Days FREE Trial $291M x -19.4x
SOLV Unlock Forecast - 30 Days FREE Trial $12387M 32.6x 3.4x
SRTS Unlock Forecast - 30 Days FREE Trial $53M 31.6x 1.0x
SSKN Unlock Forecast - 30 Days FREE Trial $8M -8.0x 25.6x
STIM Unlock Forecast - 30 Days FREE Trial $178M -1.0x 6.6x
STME Unlock Forecast - 30 Days FREE Trial $20M x x
STSS Unlock Forecast - 30 Days FREE Trial $5M -2.5x 0.3x
SYK Unlock Forecast - 30 Days FREE Trial $142678M 48.9x 12.2x
TCMD Unlock Forecast - 30 Days FREE Trial $324M 21.4x 1.7x
TELA Unlock Forecast - 30 Days FREE Trial $61M -1.8x 6.6x
TFX Unlock Forecast - 30 Days FREE Trial $5589M 29.1x 1.3x
TNDM Unlock Forecast - 30 Days FREE Trial $999M -17.1x 7.5x
TNON Unlock Forecast - 30 Days FREE Trial $9M -0.3x 1.4x
USAQ Unlock Forecast - 30 Days FREE Trial $2M x x
UTMD Unlock Forecast - 30 Days FREE Trial $191M 15.2x 1.6x
VERO Unlock Forecast - 30 Days FREE Trial $4M 0.0x 1.8x
WST Unlock Forecast - 30 Days FREE Trial $19211M 39.4x 6.6x
XTNT Unlock Forecast - 30 Days FREE Trial $99M -478.8x 2.0x

Frequently Asked Questions - LENSAR, Inc. Stock Forecast

How accurate are LENSAR, Inc. stock predictions?

Our AI model demonstrates 62% historical accuracy for LNSR predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence LENSAR, Inc. stock price forecasts?

Our analysis considers LENSAR, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is LENSAR, Inc. a good investment in 2025?

Based on our AI analysis, LENSAR, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are LENSAR, Inc. forecasts updated?

LENSAR, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced LENSAR, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for LENSAR, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...